Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,779.00
Bid: 1,778.00
Ask: 1,780.00
Change: -4.00 (-0.22%)
Spread: 2.00 (0.112%)
Open: 1,794.00
High: 1,796.00
Low: 1,773.00
Prev. Close: 1,783.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New nuclear joint venture in China

30 Oct 2012 07:00

RNS Number : 7879P
IMI PLC
30 October 2012
 



 

 

 

 

 

30 October 2012

 

IMI plc

New nuclear joint venture in China

 

Further to our announcement in December 2010, IMI, the global engineering group, is pleased to announce that it has signed an agreement for a new joint venture in China with Shanghai Automation Instrumentation Company Co., Ltd.("SAIC") to supply control valves into the nuclear power market. SAIC are industry leaders in controls and instrumentation technology and are already important suppliers to the Chinese nuclear industry.

 

The nuclear power market in China is the fastest growing in the world with 15 operational reactors, 27 under construction and more expected to start construction in the near future. These planned new reactors are expected to increase China's nuclear capacity to 67 gigawatts by 2020 and significantly higher thereafter. The new company will produce control valves for critical applications for these new nuclear power generation plants in a new valve production facility which will be established on Chong Ming Island of Shanghai.

 

Completion is subject to regulatory clearances and is expected to take place within 6 months.

 

Roy Twite, Executive Director, IMI plc, said:

"We are very pleased to have signed this agreement with SAIC. This is a very exciting opportunity for IMI. China is investing heavily in new nuclear power generation over the long term and this new venture will enable IMI to play a significant role in this development. We are looking forward to building a long relationship with SAIC delivering industry leading critical valve solutions to the Chinese nuclear market."

 

Enquiries to:

Will Shaw IMI plc Tel: +44 (0)121 717 3915

Rollo Head / Charlie Chichester RLM Finsbury Tel: +44 (0)207 251 3801

 

 

 

Notes to editors:

IMI is a global engineering group focused on the precise control and movement of fluids in critical applications. It works with leading international companies in over 50 countries to deliver innovative engineering solutions, built around valves and actuators, to address global trends such as climate change, resource scarcity, urbanisation and an ageing population. Its shares are listed on the London Stock Exchange and it is a member of the FTSE100. Further information is available at www.imiplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUKONRUUARUAA
Date   Source Headline
1st Aug 20229:21 amRNSTotal Voting Rights
29th Jul 20227:00 amRNSInterim Results
22nd Jul 202210:29 amRNSHolding(s) in Company
13th Jul 20223:21 pmRNSDirector/PDMR Shareholding
1st Jul 202211:25 amRNSBlock listing Interim Review
1st Jul 202211:20 amRNSTotal Voting Rights
15th Jun 20225:22 pmRNSDirector/PDMR Shareholding
13th Jun 20227:00 amRNSCompletion of Acquisition
1st Jun 202210:20 amRNSTotal Voting Rights
30th May 20227:00 amRNSProposed Acquisition
16th May 20221:57 pmRNSDirector/PDMR Shareholding
11th May 20221:43 pmRNSDirector/PDMR Shareholding
5th May 20222:12 pmRNSResult of AGM
5th May 20227:00 amRNSInterim Management Statement
3rd May 202210:01 amRNSTotal Voting Rights
21st Apr 202211:50 amRNSHolding(s) in Company
14th Apr 202212:16 pmRNSDirector/PDMR Shareholding
14th Apr 202212:15 pmRNSDirector/PDMR Shareholding
14th Apr 202212:12 pmRNSDirector/PDMR Shareholding
8th Apr 20223:18 pmRNSDirector/PDMR Shareholding
8th Apr 20223:15 pmRNSDirector/PDMR Shareholding
8th Apr 20223:07 pmRNSDirector/PDMR Shareholding
8th Apr 20223:00 pmRNSDirector/PDMR Shareholding
8th Apr 20222:53 pmRNSDirector/PDMR Shareholding
1st Apr 202210:39 amRNSTotal Voting Rights
31st Mar 20224:04 pmRNSDirector/PDMR Shareholding
31st Mar 20229:17 amRNSHolding(s) in Company
30th Mar 20226:03 pmRNSDirector/PDMR Shareholding
30th Mar 20226:02 pmRNSDirector/PDMR Shareholding
30th Mar 20225:58 pmRNSDirector/PDMR Shareholding
30th Mar 20225:57 pmRNSDirector/PDMR Shareholding
30th Mar 20225:53 pmRNSDirector/PDMR Shareholding
30th Mar 20225:49 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSDirector/PDMR Shareholding
25th Mar 20224:21 pmRNSAnnual Financial Report
22nd Mar 20225:32 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:30 pmRNSDirector/PDMR Shareholding
9th Mar 20224:52 pmRNSDirector/PDMR Shareholding
9th Mar 20224:51 pmRNSDirector/PDMR Shareholding
9th Mar 20224:49 pmRNSDirector/PDMR Shareholding
8th Mar 20223:09 pmRNSHolding(s) in Company
7th Mar 20222:24 pmRNSDirector/PDMR Shareholding
1st Mar 20225:37 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
25th Feb 20227:00 amRNSPreliminary results, year ended 31 December 2021
10th Feb 202210:53 amRNSHolding(s) in Company
9th Feb 20225:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.